Basal cell carcinoma

What changed: Basal cell carcinoma

Cancer page →

Every dated change on the records linked to Basal cell carcinoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Approval8Regulatory1Milestone6This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-08This recordBasal cell carcinoma
Facts on this page last checked
When this page itself was last checked or edited.

February 2021 · 1

2021-02-09RegulatoryCemiplimab
Cemiplimab: approval (US)
Advanced basal cell carcinoma after hedgehog inhibitor

2021 · 1

2021MilestoneCemiplimab
Cemiplimab approved after hedgehog-inhibitor failure
A milestone in how this cancer is treated.

2015 · 4

2012 · 2

2011 · 1

2011ApprovalAminolevulinic acid (topical, for photodynamic therapy)
Aminolevulinic acid (topical, for photodynamic therapy) approved in EU
Actinic keratosis; superficial and nodular basal cell carcinoma added 2017 (Ameluz)

2009 · 1

2009MilestoneVismodegib
Vismodegib phase 1 shows responses in advanced BCC (NEJM)
A milestone in how this cancer is treated.

2004 · 2

1998 · 1

1998ApprovalImiquimod
Imiquimod approved in EU
Genital warts, superficial basal cell carcinoma and actinic keratosis (Aldara)

1996 · 1

1996MilestoneBasal cell carcinoma
PTCH1 identified as the Gorlin syndrome gene
Hahn et al. and Johnson et al.: links human BCC to the Drosophila hedgehog pathway.

1970 · 1

1970ApprovalFluorouracil (5-FU)
Fluorouracil (5-FU) approved in US
Topical: actinic keratosis and superficial basal cell carcinoma